Dr Reddy's gets 8 observations from USFDA for its Duvvada facility

21 Aug 2019 Evaluate

US Food and Drug Administration (USFDA) has issued eight observations to Dr Reddy's Laboratories after the inspection of Formulations Manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam in Andhra Pradesh. The company has been issued Form 483 with 8 observations. The company will address them comprehensively within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1220.45 12.00 (0.99%)
30-Jan-2026 09:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.10
Dr. Reddys Lab 1220.45
Cipla 1320.05
Zydus Lifesciences 892.05
Lupin 2154.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×